NCT00002393View on ClinicalTrials.gov

A Study of Indinavir Taken With or Without DMP 266

PHASE3CompletedINTERVENTIONAL
Enrollment

300

Participants

Timeline

Start Date

Not specified

Conditions
HIV Infections
Interventions
DRUG

Indinavir sulfate

DRUG

Efavirenz

Trial Locations (12)

10029

Mount Sinai Med Ctr, New York

14642

Univ of Rochester Med Ctr, Rochester

23666

Hampton Roads Med Specialists, Hampton

30912

Med College of Georgia, Augusta

60610

Chicago Ctr for Clinical Research, Chicago

70122

Tulane Univ / Tulane / LSU Clinical Trials Unit, New Orleans

94118

Kaiser Foundation Hospital, San Francisco

372321302

Vanderbilt Univ, Nashville

405360084

Univ of Kentucky Med Ctr / Chandler Med Ctr, Lexington

Unknown

Southern Alberta HIV Clinic / Foot Hills Hosp, Calgary

Ottawa Gen Hosp, Ottawa

00927

Univ of Puerto Rico School of Medicine, San Juan

All Listed Sponsors
lead

Dupont Merck

INDUSTRY

NCT00002393 - A Study of Indinavir Taken With or Without DMP 266 | Biotech Hunter | Biotech Hunter